دورية أكاديمية
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis
| العنوان: | Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis |
|---|---|
| المؤلفون: | Jauslin, Petra, Kulkarni, Pooja, Li, Hanbin, Vatakuti, Suresh, Hussain, Azher, Wenning, LarissaAff2, Aff3, Kerbusch, Thomas |
| المصدر: | Clinical Pharmacokinetics. 58(8):1059-1068 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!